What is Lantheus Holdings share price today?

Lantheus Holdings (LNTH) share price today is {{live_price}}.

Can Indians buy Lantheus Holdings shares?

Yes, Indians can invest in the Lantheus Holdings (LNTH) from India. With INDmoney, you can buy Lantheus Holdings at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Lantheus Holdings at zero transaction cost.

How can I buy Lantheus Holdings shares from India?

It is very easy to buy Lantheus Holdings from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lantheus Holdings be purchased?

Yes, you can buy fractional shares of Lantheus Holdings with INDmoney app.

What are the documents required to start investing in Lantheus Holdings stocks?

To start investing in Lantheus Holdings, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Lantheus Holdings

Today’s highest price of Lantheus Holdings (LNTH) is {{1_rba_end}}. Today’s lowest price of Lantheus Holdings (LNTH) is {{1_rba_st}}.

What is today's market capitalisation of Lantheus Holdings

Today's market capitalisation of Lantheus Holdings LNTH is 5.9B

What is the 52 Week High and Low Range of Lantheus Holdings

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Lantheus Holdings is down from its 52 Week High?

Lantheus Holdings (LNTH) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Lantheus Holdings is up from its 52 Week low?

Lantheus Holdings (LNTH) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Lantheus Holdings?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Lantheus Holdings

Ms. Mary Anne Heino is the current Chief Executive Officer (CEO) of Lantheus Holdings.

Home

US Stocks

Lantheus Holdings

Lantheus Holdings (LNTH)

$85.97

-2.81

(-3.17%)▲

Market is closed - opens 7 PM, 12 Jun 2023

Insights on Lantheus Holdings

Increasing Revenue
Revenue is up for the last 9 quarters, 92.50M → 300.78M (in $), with an average increase of 12.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -119.18M → -2.80M (in $), with an average increase of 4146.0% per quarter

Performance

$85.57
$88.78
$85.97
0.47%
Downside
Day's Volatility :3.62%
Upside
3.17%
$47.46
$100.85
$85.97
44.79%
Downside
52 Weeks Volatility :52.94%
Upside
14.75%

Returns

Period	Lantheus Holdings	Sector (Health Care)	Index (Russel 2000)
3 Months	20.57%	5.1%	-0.2%
6 Months	56.45%	-5.5%	-1.5%
1 Year	34.57%	3.9%	-1.7%
3 Years	249.41%	27.0%	20.6%

Highlights

Market Capitalization	5.9B
Book Value	$6.52
Dividend Share	0.0
Dividend Yield	0.0%
Earnings Per Share (EPS)	-0.27
PEG Ratio	0.61
Wall Street Target Price	122.38

Profit Margin	-1.72%
Operating Margin TTM	9.59%

Return On Assets TTM	5.4%
Return On Equity TTM	-3.68%

Revenue TTM	1.0B
Revenue Per Share TTM	15.01
Quarterly Revenue Growth YOY	44.0%
Gross Profit TTM	581.7M
EBITDA	149.3M
Diluted Eps TTM	-0.27
Quarterly Earnings Growth YOY	3.69

EPS Estimate Current Year	5.58
EPS Estimate Next Year	6.14
EPS Estimate Current Quarter	1.26
EPS Estimate Next Quarter	1.21

Analyst Recommendation

Buy

92%Buy

7%Hold

0%Sell

Based on 14 Wall street analysts offering stock ratings for Lantheus Holdings(by analysts ranked 0 to 5 stars)

Based on 14 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 42.35%

Current $85.97

Target $122.38

Company Financials

	FY17	Y/Y Change
Revenue	331.4M	↑ 9.78%
Net Income	123.4M	↑ 361.05%
Net Profit Margin	37.23%	↑ 28.36%

	FY18	Y/Y Change
Revenue	343.4M	↑ 3.62%
Net Income	40.5M	↓ 67.16%
Net Profit Margin	11.8%	↓ 25.43%

	FY19	Y/Y Change
Revenue	347.3M	↑ 1.15%
Net Income	31.7M	↓ 21.84%
Net Profit Margin	9.12%	↓ 2.68%

	FY20	Y/Y Change
Revenue	339.4M	↓ 2.28%
Net Income	-13.5M	↓ 142.55%
Net Profit Margin	-3.97%	↓ 13.09%

	FY21	Y/Y Change
Revenue	425.2M	↑ 25.28%
Net Income	-71.3M	↑ 429.05%
Net Profit Margin	-16.76%	↓ 12.79%

	FY22	Y/Y Change
Revenue	935.1M	↑ 119.91%
Net Income	28.1M	↓ 139.38%
Net Profit Margin	3.0%	↑ 19.76%

	Q4 FY21	Q/Q Change
Revenue	129.6M	↑ 26.93%
Net Income	-40.2M	↑ 199.78%
Net Profit Margin	-31.04%	↓ 17.9%

	Q1 FY22	Q/Q Change
Revenue	208.9M	↑ 61.22%
Net Income	43.0M	↓ 206.83%
Net Profit Margin	20.57%	↑ 51.61%

	Q2 FY22	Q/Q Change
Revenue	223.7M	↑ 7.11%
Net Income	43.1M	↑ 0.22%
Net Profit Margin	19.25%	↓ 1.32%

	Q3 FY22	Q/Q Change
Revenue	239.3M	↑ 6.96%
Net Income	61.2M	↑ 42.21%
Net Profit Margin	25.59%	↑ 6.34%

	Q4 FY22	Q/Q Change
Revenue	263.2M	↑ 9.98%
Net Income	-119.2M	↓ 294.64%
Net Profit Margin	-45.29%	↓ 70.88%

	Q1 FY23	Q/Q Change
Revenue	300.8M	↑ 14.29%
Net Income	-2.8M	↓ 97.64%
Net Profit Margin	-0.93%	↑ 44.36%

	FY17	Y/Y Change
Total Assets	383.9M	↑ 50.0%
Total Liabilities	360.6M	↓ 0.51%

	FY18	Y/Y Change
Total Assets	439.8M	↑ 14.58%
Total Liabilities	368.8M	↑ 2.29%

	FY19	Y/Y Change
Total Assets	405.9M	↓ 7.71%
Total Liabilities	291.3M	↓ 21.02%

	FY20	Y/Y Change
Total Assets	869.8M	↑ 114.28%
Total Liabilities	355.6M	↑ 22.07%

	FY21	Y/Y Change
Total Assets	863.8M	↓ 0.69%
Total Liabilities	399.3M	↑ 12.3%

	FY22	Y/Y Change
Total Assets	1.3B	↑ 52.96%
Total Liabilities	874.1M	↑ 118.89%

	Q4 FY21	Q/Q Change
Total Assets	863.8M	↑ 1.88%
Total Liabilities	399.3M	↑ 14.6%

	Q1 FY22	Q/Q Change
Total Assets	933.2M	↑ 8.03%
Total Liabilities	417.3M	↑ 4.5%

	Q2 FY22	Q/Q Change
Total Assets	1.0B	↑ 8.64%
Total Liabilities	446.5M	↑ 6.99%

	Q3 FY22	Q/Q Change
Total Assets	1.1B	↑ 8.1%
Total Liabilities	457.9M	↑ 2.55%

	Q4 FY22	Q/Q Change
Total Assets	1.3B	↑ 20.56%
Total Liabilities	874.1M	↑ 90.9%

	Q1 FY23	Q/Q Change
Total Assets	1.3B	↑ 2.12%
Total Liabilities	903.8M	↑ 3.39%

	FY17	Y/Y Change
Operating Cash Flow	54.8M	↑ 10.34%
Investing Cash Flow	-16.3M	↓ 597.07%
Financing Cash Flow	-13.5M	↓ 55.49%

	FY18	Y/Y Change
Operating Cash Flow	61.2M	↑ 11.71%
Investing Cash Flow	-19.1M	↑ 17.31%
Financing Cash Flow	-4.7M	↓ 65.29%

	FY19	Y/Y Change
Operating Cash Flow	80.4M	↑ 31.36%
Investing Cash Flow	-22.1M	↑ 15.31%
Financing Cash Flow	-78.9M	↑ 1589.82%

	FY20	Y/Y Change
Operating Cash Flow	16.4M	↓ 79.6%
Investing Cash Flow	-4.9M	↓ 77.73%
Financing Cash Flow	-21.9M	↓ 72.29%

	FY21	Y/Y Change
Operating Cash Flow	53.9M	↑ 228.84%
Investing Cash Flow	3.7M	↓ 174.98%
Financing Cash Flow	-39.3M	↑ 79.92%

	Q4 FY21	Q/Q Change
Operating Cash Flow	13.9M	↑ 220.02%
Investing Cash Flow	-4.5M	↑ 87.77%
Financing Cash Flow	-2.1M	↑ 21.67%

	Q1 FY22	Q/Q Change
Operating Cash Flow	10.3M	↓ 26.1%
Investing Cash Flow	-1.4M	↓ 69.41%
Financing Cash Flow	-2.2M	↑ 3.76%

	Q2 FY22	Q/Q Change
Operating Cash Flow	72.6M	↑ 607.3%
Investing Cash Flow	-4.3M	↑ 212.45%
Financing Cash Flow	-2.0M	↓ 7.71%

	Q3 FY22	Q/Q Change
Operating Cash Flow	93.6M	↑ 28.89%
Investing Cash Flow	-6.1M	↑ 40.23%
Financing Cash Flow	-2.0M	↓ 2.59%

	Q1 FY23	Q/Q Change
Operating Cash Flow	108.5M	↑ 2.99%
Investing Cash Flow	-44.5M	-
Financing Cash Flow	-8.7M	↓ 102.73%

Technicals Summary

Sell

Neutral

Buy

Lantheus Holdings is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Lantheus Holdings	-13.18%	56.45%	34.57%	249.41%	249.41%
Neurocrine Biosciences Inc.	-3.43%	-21.81%	-0.94%	-21.05%	-5.78%
Haleon Plc Spon Ads	-7.07%	4.76%	9.99%	9.99%	9.99%
Zoetis Inc.	-11.91%	6.69%	0.99%	16.57%	87.33%
Viatris Inc.	-2.11%	-15.73%	-16.18%	-42.55%	-42.55%
Catalent, Inc.	15.54%	-14.7%	-63.62%	-48.0%	-2.17%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Lantheus Holdings	217.31	NA	0.61	5.58	-0.04	0.05	0.0	6.52
Neurocrine Biosciences Inc.	151.66	151.66	1.87	1.93	0.04	0.08	0.0	17.28
Haleon Plc Spon Ads	27.5	27.5	NA	0.0	0.05	0.04	0.01	3.54
Zoetis Inc.	35.69	35.69	3.53	5.4	45.26	0.13	0.01	9.72
Viatris Inc.	6.01	6.01	NA	2.95	0.09	0.03	0.05	17.45
Catalent, Inc.	16.84	16.84	1.18	1.37	0.09	0.04	0.0	27.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Lantheus Holdings	Buy	$5.9B	249.41%	217.31	-1.72%
Neurocrine Biosciences Inc.	Buy	$9.2B	-5.78%	151.66	4.0%
Haleon Plc Spon Ads	Buy	$38.2B	9.99%	27.5	9.86%
Zoetis Inc.	Buy	$75.6B	87.33%	35.69	25.59%
Viatris Inc.	Hold	$11.3B	-42.55%	6.01	12.05%
Catalent, Inc.	Buy	$7.1B	-2.17%	16.84	8.62%

Institutional Holdings

BlackRock Inc
12.01%
Vanguard Group Inc
10.76%
AllianceBernstein L.P.
4.16%
State Street Corporation
3.40%
Hood River Capital Management LLC
2.39%
Assenagon Asset Management SA
2.13%

Organization	Lantheus Holdings
Employees	698
CEO	Ms. Mary Anne Heino
Industry	Health Technology

Lantheus Holdings (LNTH)

Insights on Lantheus Holdings

Increasing Revenue

Increasing Net Profit